What is Cibinetide (Ara-290)? The Molecular Locksmith
    Cibinetide is a meticulously engineered, non-erythropoietic peptide, derived from the structure of Erythropoietin (EPO). Crucially, it lacks EPO's hematopoietic (blood cell-producing) activity. Its primary target is the Innate Repair Receptor (IRR), a heterodimeric complex formed by the binding of the EPO receptor (EPOR) and the beta-common receptor (βcR/CD131). Think of the IRR as a "damage sensor" switch. Cibinetide acts as a highly specific molecular key, activating this switch exclusively in damaged tissues where the IRR complex is upregulated. This targeted activation is its defining feature, differentiating it profoundly from EPO and many other growth factors.

    Understanding Cibinetide requires moving beyond simplistic "muscle-building" tropes. Its features paint a picture of a tissue repair modulator:

    1.Precision Targeting (Spatial Specificity): It only binds and activates the IRR complex. This complex is minimally expressed in healthy tissues but rapidly upregulated at sites of injury, ischemia, or inflammation. This inherent targeting minimizes off-target effects – a significant theoretical advantage.

    2.Inflammation Resolution & Tissue Healing: Activation of the IRR triggers a cascade of anti-inflammatory and pro-repair signaling pathways:

    ○TGF-β Pathway Modulation: Promotes a shift towards tissue remodeling and repair over destructive inflammation.

    ○Reduced Pro-Inflammatory Cytokines: Suppresses signals like TNF-α and IL-6 that drive tissue breakdown and pain.

    ○Enhanced Cell Survival: Activates pro-survival pathways (e.g., PI3K/Akt) in stressed or damaged cells, including neurons, endothelial cells, and potentially satellite cells (muscle stem cells).

    ○Mitochondrial Protection: Emerging evidence suggests potential roles in protecting mitochondrial function under stress, crucial for cellular energy and recovery.

    3.Neuromodulation: Significant research focuses on Cibinetide's ability to promote nerve repair and reduce neuropathic pain by activating the IRR on neuronal and glial cells. This is highly relevant to bodybuilding where nerve compression or overuse injuries are common.

    4.Non-Hematopoietic: It does not stimulate red blood cell production, eliminating risks like polycythemia associated with EPO misuse.

    Applying Cibinetide's features to bodybuilding demands a paradigm shift from direct anabolism to enhanced recovery and resilience. Its potential value lies in optimizing the environment for muscle growth and performance:

    1.Accelerated Injury Recovery & Prevention:

    ○Muscle Strain/Tear Repair: By dampening inflammation rapidly at the injury site and promoting tissue repair pathways, Cibinetide could theoretically shorten downtime from minor strains or microtears common in intense training. Its targeted action could mean faster resolution of local inflammation without systemic immunosuppression.

    ○Tendon/Ligament Healing: Chronic tendonitis (e.g., rotator cuff, tennis elbow) plagues lifters. Cibinetide's anti-inflammatory and pro-repair effects on connective tissue offer a theoretical pathway to faster healing and reduced pain, potentially allowing more consistent training.

    ○Joint Inflammation Management: While not a direct cartilage builder, modulating inflammatory cascades within joints could reduce training-limiting pain and swelling associated with conditions like mild osteoarthritis or synovitis.

    2.Neuropathy Management for Pain-Free Training: Heavy lifting, poor form, or chronic overuse can lead to peripheral nerve irritation or compression (e.g., carpal tunnel symptoms, sciatica-like pain). Cibinetide's clinically studied neuroprotective and neuroregenerative effects offer a novel theoretical approach to managing such training-induced neuropathic pain, improving training comfort and consistency.

    3.Enhanced Recovery from Training Stress (Metabolic Priming): Intense training creates localized tissue stress, inflammation, and oxidative damage. By activating the IRR in stressed muscle tissue, Cibinetide might:

    ○Accelerate the resolution of exercise-induced inflammation, shifting the tissue environment faster from catabolic breakdown to anabolic repair.

    ○Improve cellular (including satellite cell) survival post-stress, potentially preserving the pool of cells available for repair and growth.

    ○Mitigate mitochondrial dysfunction induced by extreme metabolic stress, supporting sustained energy production and recovery. This is highly speculative but mechanistically plausible based on its cell-protective actions.

    4.Potential Synergy in Peptide Stacks: Its unique mechanism suggests potential synergy with other peptides:

    ○With BPC-157/TB-500: Combining Cibinetide's targeted inflammation resolution and cell protection with BPC-157's angiogenic/growth factor stimulation and TB-500's actin regulation could create a potent theoretical "recovery stack" for significant injuries.

    ○With GHRPs/GHRHs: By improving the tissue environment (reducing inflammation, potentially protecting nerves/joints), Cibinetide might allow for more consistent application of growth hormone secretagogues, maximizing their anabolic potential indirectly. This is highly theoretical.

    Benefits often cited within bodybuilding circles are largely extrapolated from preclinical and limited clinical data in other conditions (diabetic neuropathy, sarcoidosis). Key theoretical benefits include:

    1.Reduced Training-Induced Inflammation: Faster resolution of localized muscle and joint inflammation post-workout.

    2.Accelerated Soft Tissue Healing: Potential for quicker recovery from minor strains, tendonitis, or ligament irritation.

    3.Neuropathic Pain Relief: Management of nerve-related pain stemming from heavy lifting or overuse, improving training tolerance.

    4.Improved Training Consistency: By mitigating pain and accelerating recovery from minor setbacks, potentially allowing for more frequent and intense sessions.

    5.Reduced Systemic Inflammation Burden: Targeted action might lower chronic low-grade inflammation associated with hard training, potentially improving overall well-being and metabolic health.

    6.Potential Nerve Protection: Theoretical safeguard against chronic nerve compression damage in vulnerable areas.

    Crucially Missing: Robust, direct evidence of Cibinetide causing significant hypertrophy or strength gains in healthy or training athletes. Its benefits are primarily supportive to the training process by enhancing recovery and reducing limitations.

    Disclaimer: Human data for bodybuilding use is non-existent. Information below is inferred from clinical trials for other indications (typically neurological) and peptide pharmacokinetics. This is NOT a recommendation.

    ●Dosage (10mg Vial Context): Clinical trials often used doses ranging from 1mg to 4mg administered subcutaneously (SC) daily or every other day for several weeks. A 10mg vial suggests a common research practice of reconstitution allowing for multiple doses. A typical speculative research dose extrapolated for potential recovery/neuropathy effects might be in the range of 1mg to 2mg injected subcutaneously, once daily or potentially every other day. Higher doses (e.g., 4mg) were used in some neuropathy trials but offer diminishing returns and increased cost/risk without proven bodybuilding benefit. Starting at the lower end (e.g., 1mg daily) is prudent.

    ●Cycle Duration: Clinical trials typically ran for 4 to 12 weeks. For managing chronic issues like tendonitis or neuropathy, a cycle of 6-8 weeks is often speculated. For acute injury recovery, a shorter cycle of 4-6 weeks might be hypothesized. Due to its mechanism targeting repair processes, longer cycles might be considered, but safety data is lacking. Cycles exceeding 8-12 weeks lack justification.

    ●Half-Life: Cibinetide has a relatively short half-life, estimated to be in the range of 2-4 hours based on its peptide structure and preclinical data. This necessitates frequent administration (daily or EOD) to maintain consistent receptor activation and biological effect. Its action, however, triggers signaling cascades that outlast its direct presence in the bloodstream (e.g., altered gene expression, sustained anti-inflammatory mediator release).

    ●Administration: Exclusively subcutaneous injection. Intramuscular injection near a training-stressed muscle is theoretically conceivable but unsupported and risks unpredictable localized effects or irritation. SC into abdominal or thigh fat is standard.

    PTC refers to the period after discontinuing a compound where effects persist or require management. For Cibinetide:

    1.No Direct Rebound: Unlike hormones (testosterone, SARMs), Cibinetide doesn't suppress the HPTA or have a known "rebound" effect upon cessation. Its action is receptor-mediated signaling, not altering endogenous hormone production.

    2.Sustained Biological Effects: The cellular changes it induces (reduced inflammation, initiated repair pathways, nerve protection) likely have effects that persist beyond its clearance. The resolution of inflammation or ongoing tissue repair might continue for days or weeks after stopping. Nerve repair is a slow process potentially continuing long after.

    3.No Mandatory PCT: There is no established Post-Treatment Cycle protocol like SERMs for steroids. The focus post-cycle is simply monitoring the condition it was used for (e.g., pain levels, injury recovery progress).

    4.Potential Need for Re-Cycling: If the underlying issue (e.g., chronic tendonitis, neuropathy) is persistent, symptoms may gradually return after stopping, potentially necessitating another cycle later. This isn't "PTC" but rather managing a chronic condition.

    1.Lack of Bodybuilding Evidence: This cannot be overstated. All proposed benefits are theoretical extrapolations. There are no controlled studies on Cibinetide for muscle growth, strength, or athletic performance enhancement in healthy individuals.

    2.Research Chemical Status: Sold strictly for "research purposes," meaning purity, sterility, and accurate dosing are not guaranteed. Contamination or under-dosing is a significant risk.

    3.Unknown Long-Term Safety: Safety data beyond several months is lacking. Potential off-target effects, immune modulation consequences, or impacts on other repair pathways are unknown.

    4.Cost: Cibinetide is typically expensive compared to more established peptides or supplements, making its speculative use potentially inefficient.

    5.Injection Risks: Any injection carries risks of infection, abscess, nerve damage, or localized reaction.

    6.Regulatory Status: Not approved for any athletic or bodybuilding use. Possession or use may violate anti-doping rules (WADA status is unclear but risk exists) or local laws.

    7.Misplaced Expectations: It is NOT a potent anabolic agent. Expecting dramatic muscle gains is unrealistic. Its value, if any, lies in subtle recovery enhancement and pain management.

    8.Underlying Conditions: Masking pain without addressing the root cause (e.g., poor form, overtraining, structural issue) can lead to more severe injury.

Trade names	Cibinetide,ARA-290; ARA290; PHBSP,pHBSP peptide; pGlu-Glu-Gln-Leu-Glu-Arg-Ala-Leu-Asn-Ser-Ser; Pyroglutamate helix B surface peptide; UEQLERALNSS
CAS	1208243-50-8
Molar mass	1257.324
Formula	C51H84N16O21
Purity	Above 98%
Apprarance	10mg/vial, 10vials/box

 

 

Any needs, please contact us

Email: Jasonraws106@gmail.com

WhatsApp: +86-15572565525
Telegram: +86-15871669785

   

                                   

 

    Cibinetide (Ara-290) 10mg represents a fascinating intersection of immunology and tissue repair biology. Its unique mechanism as a targeted activator of the Innate Repair Receptor offers a theoretical pathway to accelerate recovery from training-induced soft tissue damage and manage neuropathic pain in a bodybuilding context. The potential lies in creating a more favorable internal environment – reducing inflammation, protecting stressed cells, and promoting healing – thereby indirectly supporting consistent, intense training, which is the true driver of hypertrophy.

    However, it is paramount to dispel the notion that Cibinetide is a direct muscle-building compound. Robust evidence for its efficacy and safety in athletic populations is absent. Its short half-life necessitates frequent dosing, cost is significant, and sourcing poses purity risks. The benefits are subtle and supportive, focused on resilience and recovery, not explosive growth.

    For the bodybuilder, foundational elements – progressive overload, meticulous nutrition, adequate sleep, and intelligent programming – remain irreplaceable. Cibinetide, if explored at all, should be viewed strictly as a highly speculative, potential adjunct for overcoming specific, persistent recovery hurdles or nerve-related pain, approached with extreme caution, managed expectations, and full awareness of the significant knowledge gaps and risks involved. Its true value in this domain remains firmly within the realm of research, not established practice.

Hot Tags: cibinetide(ara-290)10mg for bodybuilding cas:1208243-50-8, China cibinetide(ara-290)10mg for bodybuilding cas:1208243-50-8 manufacturers, suppliers, factory